2 patents
Utility
Reagents for Treatment of Oculopharyngeal Muscular Dystrophy (OPMD) and Use Thereof
24 Feb 22
The present disclosure relates to RNA interference (RNAi) reagents, such as short hairpin microRNA (shmiR) and short hairpin RNA (shRNA), for treatment of oculopharyngeal muscular dystrophy (OPMD), compositions comprising same, and use thereof to treat individuals suffering from OPMD or which are predisposed thereto.
Vanessa Strings-Ufombah, David Suhy
Filed: 1 Sep 21
Utility
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
12 Oct 21
The present disclosure relates to RNA interference (RNAi) reagents, such as short hairpin microRNA (shmiR) and short hairpin RNA (shRNA), for treatment of oculopharyngeal muscular dystrophy (OPMD), compositions comprising same, and use thereof to treat individuals suffering from OPMD or which are predisposed thereto.
Vanessa Strings-Ufombah, David Suhy
Filed: 14 Dec 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first